All News

Drug candidate can treat individuals who have PTSD associated with their military service.

Rubraca is the latest targeted agent that treats cancers caused by specific mutations in a patient’s gene.

The FDA has granted orphan drug designation to AbbVie for risankizumab (ABBV-066) for the treatment of Crohn’s disease in pediatric patients.

As the year comes to an end, pharmacy students may be looking forward to a much needed semester break.

It’s that time of the year again where we all feed our faces and start to dread stepping back on the scale. You want to lose the weight but you just can’t stop eating. You keep telling yourself you will start your diet Monday or after the holidays. Not only is all of the food you’re ingesting adding numbers to the scale, but it’s also putting you at an increased risk of developing diseases such as congestive heart disease, hypertension, stroke, type 2 diabetes, and various cancers. Here is some information that may help you keep the weight off and start shedding some pounds.

Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, clinical trial.

Officials with Mylan have announced the launch of generic EpiPen (epinephrine injection, USP) Auto-Injector at half the cost of its brand name counterpart.

In a letter to the new power structure in Washington, D.C., the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), and the National Alliance of State Pharmacy Associations (NASPA) have detailed steps necessary to leverage pharmacy patient care and prevent higher costs that result from untreated conditions.

FDA grants accelerated approval for rucaparib (Rubraca) to treat advanced ovarian cancer.

Officials with Clovis Oncology announced today they have received accelerated FDA approval for Rubraca (rucaparib) to treat advanced ovarian cancers in women.

Pembrolizumab was associated with clinically meaningful improvements in quality of life over chemotherapy.

Mylan pledges to manufacture affordable drugs in the midst of price-fixing allegations.

Researchers discovered a statistically significant link between diabetes and all-cause mortality.

Anti-inflammatory drugs suppress PGE2 production and leads to adverse events from peripheral blood hematopoietic stem cell harvesting.

Integrase inhibitors can reduce the HIV viral load to decrease transmission of the disease.

Integrase inhibitors reduce HIV viral load in the blood and semen.

Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.

A new vaccine prevents euphoria associated with opioids.

Healthy People 2020, the national health promotion and disease intervention initiative, set the goal influenza vaccination rate in the community at 70%. Despite this goal, reports show that vaccination rates are way under expectations at 44%.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

ICER seeks comment on the effectiveness and value of disease modifying therapies for relapsing remitting and primary progressive multiple sclerosis.

Global HIV incidence rates drop in some African countries.

FDA finds no association between neuropsychiatric events and the smoking-cessation medication Chantix.

ICER seeks data on the effectiveness and value of disease modifying therapies for relapsing remitting and primary progressive multiple sclerosis.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

A star-shaped delivery device could prevent medication adherence.

Rates of suicide elevated in cancer survivors diagnosed before the age of 25 years.